LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 11 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 1. - Dataset (ID:20248)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|
BT-20 | NU7441 | 1.11 | uM | LJP5 | 72 | hr | 1657 | 5599 | 5588 | 1.0019 | 1.0015 |
BT-20 | NU7441 | 3.33 | uM | LJP5 | 72 | hr | 1657 | 5366 | 5588 | 0.9601 | 0.9534 |
BT-20 | NU7441 | 10 | uM | LJP5 | 72 | hr | 1657 | 2467 | 5588 | 0.4415 | 0.2543 |
BT-20 | OSI-027 | 0.04 | uM | LJP6 | 72 | hr | 1657 | 5567 | 5383 | 1.0327 | 1.0362 |
BT-20 | OSI-027 | 0.12 | uM | LJP6 | 72 | hr | 1657 | 4303 | 5383 | 0.7979 | 0.7485 |
BT-20 | OSI-027 | 0.37 | uM | LJP6 | 72 | hr | 1657 | 3446 | 5383 | 0.6390 | 0.5342 |
BT-20 | OSI-027 | 1.11 | uM | LJP6 | 72 | hr | 1657 | 2944 | 5383 | 0.5465 | 0.4008 |
BT-20 | OSI-027 | 3.33 | uM | LJP6 | 72 | hr | 1657 | 2599 | 5383 | 0.4819 | 0.2988 |
BT-20 | OSI-027 | 10 | uM | LJP6 | 72 | hr | 1657 | 2255 | 5383 | 0.4188 | 0.1965 |
BT-20 | WYE-125132 | 0.04 | uM | LJP6 | 72 | hr | 1657 | 3100 | 5383 | 0.5767 | 0.4464 |
BT-20 | WYE-125132 | 0.12 | uM | LJP6 | 72 | hr | 1657 | 2553 | 5383 | 0.4748 | 0.2899 |
BT-20 | WYE-125132 | 0.37 | uM | LJP6 | 72 | hr | 1657 | 2430 | 5383 | 0.4519 | 0.2530 |
BT-20 | WYE-125132 | 1.11 | uM | LJP6 | 72 | hr | 1657 | 2233 | 5383 | 0.4153 | 0.1920 |
BT-20 | WYE-125132 | 3.33 | uM | LJP6 | 72 | hr | 1657 | 2216 | 5383 | 0.4119 | 0.1865 |
BT-20 | WYE-125132 | 10 | uM | LJP6 | 72 | hr | 1657 | 2019 | 5383 | 0.3753 | 0.1232 |
BT-20 | Barasertib | 0.04 | uM | LJP5 | 72 | hr | 1657 | 5249 | 5588 | 0.9396 | 0.9300 |
BT-20 | Barasertib | 0.12 | uM | LJP5 | 72 | hr | 1657 | 4476 | 5588 | 0.8011 | 0.7621 |
BT-20 | Barasertib | 0.37 | uM | LJP5 | 72 | hr | 1657 | 3393 | 5588 | 0.6072 | 0.5041 |
BT-20 | Barasertib | 1.11 | uM | LJP5 | 72 | hr | 1657 | 2554 | 5588 | 0.4573 | 0.2792 |
BT-20 | Barasertib | 3.33 | uM | LJP5 | 72 | hr | 1657 | 2292 | 5588 | 0.4103 | 0.2029 |
BT-20 | Barasertib | 10 | uM | LJP5 | 72 | hr | 1657 | 1851 | 5588 | 0.3313 | 0.0649 |
BT-20 | Vemurafenib | 0.04 | uM | LJP5 | 72 | hr | 1657 | 5732 | 5588 | 1.0264 | 1.0291 |
BT-20 | Vemurafenib | 0.12 | uM | LJP5 | 72 | hr | 1657 | 5716 | 5588 | 1.0232 | 1.0263 |
BT-20 | Vemurafenib | 0.37 | uM | LJP5 | 72 | hr | 1657 | 5543 | 5588 | 0.9918 | 0.9902 |
BT-20 | Vemurafenib | 1.11 | uM | LJP5 | 72 | hr | 1657 | 5543 | 5588 | 0.9922 | 0.9910 |